Welcome to LookChem.com Sign In|Join Free

CAS

  • or

134997-87-8

Post Buying Request

134997-87-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

134997-87-8 Usage

Uses

3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carboxylic Acid can be used as poly(ADP-ribose) polymerase (PARP) inhibitors to treat diseases.

Check Digit Verification of cas no

The CAS Registry Mumber 134997-87-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,9,9 and 7 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 134997-87:
(8*1)+(7*3)+(6*4)+(5*9)+(4*9)+(3*7)+(2*8)+(1*7)=178
178 % 10 = 8
So 134997-87-8 is a valid CAS Registry Number.
InChI:InChI=1/C9H7NO4/c11-8-4-14-7-2-1-5(9(12)13)3-6(7)10-8/h1-3H,4H2,(H,10,11)(H,12,13)

134997-87-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carboxylic acid

1.2 Other means of identification

Product number -
Other names 3-oxo-4H-1,4-benzoxazine-6-carboxylic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:134997-87-8 SDS

134997-87-8Relevant articles and documents

NEW HETEROCYCLIC COMPOUNDS

-

Page/Page column 67-68, (2019/06/17)

The invention provides new heterocyclic compounds having the general formula (IA) wherein A, L, X, Y, m, n, R1 and R2 are as described herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.

SMYD INHIBITORS

-

Paragraph 0850; 0853-0855, (2017/07/18)

The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.

MORPHOLINYL AND PYRROLIDINYL ANALOGS

-

Page/Page column 122-123, (2008/06/13)

The present invention relates to morpholinyl, and pyrrolidinyl analogs, pharmaceutical compositions containing them, and their use as antagonists of urotensin II.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 134997-87-8